Fundraising FoxSpringdale Ventures — 2020 Investments
6 investments dated 2020 · listed companies and verified rows first · show all
Caraway Therapeutics was a preclinical biopharmaceutical company developing small-molecule therapies modulating lysosomal function to treat neurodegenerative and rare diseases.
BiotechHealthtech
Co-investorsDementia Discovery FundEisai Innovation, Inc.McCarthy CapitalMRL Ventures FundSV Health InvestorsAbbVie+9 more
Co-investorsElizabeth Street VenturesGaingelsReshape
__Twitter.png)
KOS produces organic plant-based protein powders sold directly to consumers.
ConsumerDirect to ConsumerFoodTechHealthtechWellness & Fitness
Co-investorsLead Edge Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Foodstirs Junk-Free BakeryKOS NaturalsUnion Whole Earth Snacks
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.